<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2022.122003</article-id><article-id pub-id-type="publisher-id">OJGas-115245</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  &lt;i&gt;Helicobacter pylori&lt;/i&gt; Infection and Gastroduodenal Lesions: Prevalence and Associated Factors in Cote d’Ivoire
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Diakité</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amadou</surname><given-names>Koné</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akoun</surname><given-names>Fabrice Aké</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kouassi</surname><given-names>Olivier Claver Koffi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anassi</surname><given-names>Jean Baptiste Okon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kadidiatou</surname><given-names>Diallo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Faculty of Medical Sciences, Alassane Ouattara University, Bouaké, Cote d’Ivoire</addr-line></aff><aff id="aff1"><addr-line>Department of Medicine and Hepato-Gastroenterology, Teaching Hospital of Bouaké, Bouaké, Cote d’Ivoire</addr-line></aff><pub-date pub-type="epub"><day>16</day><month>02</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>27</fpage><lpage>35</lpage><history><date date-type="received"><day>27,</day>	<month>December</month>	<year>2021</year></date><date date-type="rev-recd"><day>14,</day>	<month>February</month>	<year>2022</year>	</date><date date-type="accepted"><day>17,</day>	<month>February</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  O
  bjective:
   
  The objective is 
  to determine the prevalence of Helicobacter pylori (Hp) infection and highlight the determinants of the infection as well as the gastric histopathological lesions associated with this infection. <b>Methods:</b> This is a retrospective study carried out from August 01, 2015 to December 31, 2020 in Bouak&#233;. It included all patients with gastric and/or duodenal lesion on upper gastrointestinal endoscopy in whom gastric biopsies and histopathology results are available. <b>Results:</b> The study involved 510 patients (301 men and 209 women). The prevalence of Hp was 66.47% (339/510 patients). The presence of Hp was not significantly related to age and gender. Epigastralgia was the most common indication with no significant difference between the positive and negative Hp groups (65.37% vs 34.63%, p = 0.35). A significant difference was only observed for duodenal ulcers (84.31% Hp+ vs
   15.69% Hp-
  ,
   p = 0.004). Regarding histological lesions: Chronic and active gastritis was strongly related to the presence of Hp (p &lt; 0.05). Intestinal metaplasia and gastric atrophy were not significantly associated with the presence of Hp. These precursor lesions of gastric cancer (metaplasia and atrophy) were, however, significantly related to chronic gastric disease with p = 0.02 and p &lt; 0.001, respectively. <b>Conclusion:</b> The prevalence of Hp is high in Bouak&#233;. Our study confirms the link between Hp infection and chronic and active gastritis.
 
</p></abstract><kwd-group><kwd>&lt;i&gt;Helicobacter Pylori&lt;/i&gt;</kwd><kwd> Gastritis</kwd><kwd> Atrophy</kwd><kwd> Intestinal Metaplasia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Since its discovery in 1981 by Barry Marshall and Robin Warren, Helicobacter pylori (Hp) established itself as a bacterium of major importance in the genesis of pathologies in gastroenterology [<xref ref-type="bibr" rid="scirp.115245-ref1">1</xref>]. The links between chronic gastritis (CG) due to Hp, peptic ulcers (PU) and some gastric cancers (adenocarcinomas and MALT gastric lymphomas) are well established [<xref ref-type="bibr" rid="scirp.115245-ref2">2</xref>]. Its global prevalence is in the order of 50%, predominant in Africa, Asia, Central and South America [<xref ref-type="bibr" rid="scirp.115245-ref1">1</xref>]. In developing countries, it affects about 80% of the population with transmission occurring very early in childhood [<xref ref-type="bibr" rid="scirp.115245-ref3">3</xref>]. The factors that influence the incidence and prevalence of Hp infection are age, gender, geographic and socio-economic factors [<xref ref-type="bibr" rid="scirp.115245-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref3">3</xref>]. Among the diagnostic methods of Hp, the pathological examination of gastric biopsies performed during digestive endoscopy is most commonly used because of its high specificity and sensitivity that are greater than 90% [<xref ref-type="bibr" rid="scirp.115245-ref4">4</xref>]. Despite the improvement in living standards and the introduction of new Hp eradication protocols, the prevalence of this bacterium and its involvement in the genesis of gastric lesions remain a concern as well in Africa, in Asia and in the low-prevalence countries [<xref ref-type="bibr" rid="scirp.115245-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref6">6</xref>]. In C&#244;te d’Ivoire, few studies exist on the relationship between Hp and gastric lesions since the advent of quadruple therapy [<xref ref-type="bibr" rid="scirp.115245-ref7">7</xref>]. The purpose of this study is to determine the prevalence of Hp infection and to identify the determinants of infection as well as the gastroduodenal histopathological lesions associated with this infection.</p></sec><sec id="s2"><title>2. Methods</title><p>This was a retrospective study covering the period from 1 August 2015 to 31 December 2020. Our study was carried out on the basis of digestive endoscopy reports from 3 digestive endoscopy centres in Bouak&#233; (Bouak&#233; Teaching Hospital, Holy Fraternity Clinic and Notre Dame des Ap&#244;tres Clinic). The study population consisted of patients who performed upper digestive endoscopy during the study period in one of the 3 centres.</p><p>We included in the study, patients in whom gastric biopsies (fundal and antral) had been performed and with pathological result from the available biopsies. For patients who performed multiple upper digestive endoscopies, only the results of the initial endoscopy and histological examination were considered for the study. On the upper gastrointestinal endoscopy reports, we collected data on age, gender, occupation, examination indications, description of gastric and duodenal lesions. The histological gastric lesions in accordance with Sydney’s categorization criteria (chronic gastritis, active gastritis, glandular atrophy, intestinal metaplasia, dysplasia and gastric cancer) and the presence or absence of Hp were also collected from the histological report of the gastric biopsies.</p><p>Epi info 7 software was used for data entry and analysis. Differences in the distribution of variables were evaluated by the Chi-square test and those with a p-value of &lt;0.05 were considered statistically significant. Odds ratios (OR) and respective 95% confidence intervals (95% CI) were calculated for each gastric cancer precursor lesion in relation to the presence of H. pylori infection.</p>Ethics<p>The study was carried out with the approval of the Scientific Medical Director of the Bouak&#233;’s Teaching Hospital. Confidentiality was respected by assigning an anonymity number to each investigation report.</p></sec><sec id="s3"><title>3. Results</title><p>A total of 510 patients who met the criteria were considered in our study. The average age was 51.40 years with extremes ranging from 13 to 89 years, divided into age groups of less than 30 years (8.43%), 30 to 50 years (40.20%), 51 to 70 years (42.75%) and 71 to 90 years (8.63%). The majority of patients included were male at 59% (sex ratio 1.44). The 510 patients resided in 70% urban areas and 30% in rural areas. More than half of the patients were unemployed (25.10%) and in the informal sector (26.85%).</p><p>The overall prevalence of Hp infection was 66.47% (339/510). There was no significant difference between men (199/301) and women (140/209) for Hp prevalence (p = 0.84). There was no significant difference between Hp (+) and Hp (−) patients for different age groups (p = 0.48), gender (male/female, p = 0.84) and area of residence (Urban/rural, p = 0.19) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>The most common indication of gastroscopy was epigastralgia (75.8%) with no significant difference between Hp (+) and (−) patients (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>The most common endoscopic lesions were gastric erythema (65.10%) and gastric ulcers (29.60%) with no significant difference between positive and negative Hp patients. A significant difference was observed only for duodenal ulcers (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of age, gender, place of residence and hospitalization according toH. pylori status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >H. pylori Status</th><th align="center" valign="middle" >Total n = 510</th><th align="center" valign="middle" >Hp (+) n = 339 (66.47%)</th><th align="center" valign="middle" >Hp (−) n = 171 (33.53%)</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >301 (59.01%)</td><td align="center" valign="middle" >199 (66.11%)</td><td align="center" valign="middle" >102 (33.89%)</td><td align="center" valign="middle" >0.84</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >209 (40.98%)</td><td align="center" valign="middle" >140 (66.99%)</td><td align="center" valign="middle" >69 (33.01%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Average age</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >51 years old</td><td align="center" valign="middle" >52.6 years old</td><td align="center" valign="middle" >0.2</td></tr><tr><td align="center" valign="middle" >Age group 10 - 30 years old 31 - 50 years old 51 - 70 years old 71 - 90 years old</td><td align="center" valign="middle" >43 (8.43%) 205 (40.19%) 218 (42.74%) 44 (8.62%)</td><td align="center" valign="middle" >31 (72.09%) 138 (67.32%) 138 (63.30%) 32 (72.73%)</td><td align="center" valign="middle" >12 (27.91%) 67 (32.68%) 80 (36.70%) 12 (27.27%)</td><td align="center" valign="middle" >0.48</td></tr><tr><td align="center" valign="middle" >Residence</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Rural</td><td align="center" valign="middle" >151 (29.60%)</td><td align="center" valign="middle" >94 (62.25%)</td><td align="center" valign="middle" >57 (37.75%)</td><td align="center" valign="middle" >0.19</td></tr><tr><td align="center" valign="middle" >Urban</td><td align="center" valign="middle" >359 (70.40%)</td><td align="center" valign="middle" >245 (68.25%)</td><td align="center" valign="middle" >114 (31.75%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hospitalization</td><td align="center" valign="middle" >57 (11.11%)</td><td align="center" valign="middle" >33 (57.89)</td><td align="center" valign="middle" >24 (42.11)</td><td align="center" valign="middle" >0.15</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of indications for upper gastrointestinal endoscopy in 510 patients according to the presence of Hp</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >H. pylori Status</th><th align="center" valign="middle" >Total n = 510</th><th align="center" valign="middle" >Hp (+) n = 339</th><th align="center" valign="middle" >Hp (−) n = 171</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >Epigastralgia</td><td align="center" valign="middle" >387 (75.90%)</td><td align="center" valign="middle" >253 (65.37%)</td><td align="center" valign="middle" >134 (34.63%)</td><td align="center" valign="middle" >0.35</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >57 (11.17%)</td><td align="center" valign="middle" >35 (61.40%)</td><td align="center" valign="middle" >22 (38.60%)</td><td align="center" valign="middle" >0.39</td></tr><tr><td align="center" valign="middle" >Upper duodenal hemorrhage (UDH)</td><td align="center" valign="middle" >52 (10.19%)</td><td align="center" valign="middle" >39 (75.00%)</td><td align="center" valign="middle" >13 (25.00%)</td><td align="center" valign="middle" >0.16</td></tr><tr><td align="center" valign="middle" >Cirrhosis chech-up</td><td align="center" valign="middle" >16 (3.13%)</td><td align="center" valign="middle" >11 (68.75%)</td><td align="center" valign="middle" >5 (31.25%)</td><td align="center" valign="middle" >0.84</td></tr><tr><td align="center" valign="middle" >Weight-loss</td><td align="center" valign="middle" >13 (2.54%)</td><td align="center" valign="middle" >5 (38.46%)</td><td align="center" valign="middle" >8 (61.54%)</td><td align="center" valign="middle" >0.03</td></tr><tr><td align="center" valign="middle" >Gastro-oesophageal reflux disease (GERD)</td><td align="center" valign="middle" >11 (2.15%)</td><td align="center" valign="middle" >8 (66.67%)</td><td align="center" valign="middle" >3 (33.33%)</td><td align="center" valign="middle" >0.98</td></tr><tr><td align="center" valign="middle" >Dysphagia</td><td align="center" valign="middle" >12 (2.35%)</td><td align="center" valign="middle" >8 (66.67%)</td><td align="center" valign="middle" >4 (33.33%)</td><td align="center" valign="middle" >0.98</td></tr><tr><td align="center" valign="middle" >Anaemia</td><td align="center" valign="middle" >10 (1.96%)</td><td align="center" valign="middle" >6 (60. 00%)</td><td align="center" valign="middle" >4 (40.00%)</td><td align="center" valign="middle" >0.66</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of endoscopic lesions according to the presence of Hp</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >H. pylori Status</th><th align="center" valign="middle" >Hp (+) n = 339</th><th align="center" valign="middle" >Hp (−) n = 171</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >Gastric erythema</td><td align="center" valign="middle" >245 (69.01%)</td><td align="center" valign="middle" >110 (30.99%)</td><td align="center" valign="middle" >0.06</td></tr><tr><td align="center" valign="middle" >Gastric ulcers</td><td align="center" valign="middle" >104 (68.87%)</td><td align="center" valign="middle" >47 (31.13%)</td><td align="center" valign="middle" >0.45</td></tr><tr><td align="center" valign="middle" >Duodenal ulcer</td><td align="center" valign="middle" >43 (84.31%)</td><td align="center" valign="middle" >8 (15.69%)</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >Gastric erosions</td><td align="center" valign="middle" >60 (67.42%)</td><td align="center" valign="middle" >29 (32.58%)</td><td align="center" valign="middle" >0.83</td></tr><tr><td align="center" valign="middle" >Gastric ulcerations</td><td align="center" valign="middle" >46 (71.88%)</td><td align="center" valign="middle" >18 (28.13%)</td><td align="center" valign="middle" >0.32</td></tr><tr><td align="center" valign="middle" >Gastric tumors</td><td align="center" valign="middle" >20 (37.04)</td><td align="center" valign="middle" >34 (62.96%)</td><td align="center" valign="middle" >0.001</td></tr></tbody></table></table-wrap><p>For histological lesions: Chronic and active gastritis were strongly related to the presence of Hp (respectively OR = 77.79 [30 - 187]; p = 0.001 and 260 [106 - 640]; p = 0.001). Gastric malignancies, on the other hand, were significantly related to the absence of Hp (OR = 0.19 [0.1 - 0.35]; p = 0.001). Intestinal metaplasia and gastric atrophy were not significantly associated with the presence of Hp (<xref ref-type="table" rid="table4">Table 4</xref>). These precursor lesions of gastric cancer (intestinal metaplasia and glandular atrophy) were, on the other hand, significantly related to chronic gastric univariate analysis with p = 0.02 and p = 0.001 respectively (<xref ref-type="table" rid="table5">Table 5</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>The results of this work show a high frequency of Hp infection in our study population. In developing countries, Hp infections affect about 80% of the population with transmission occurring very early in childhood [<xref ref-type="bibr" rid="scirp.115245-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref3">3</xref>].</p><p>In this study, the higher prevalence of Hp in men at 58.70% compared to 41.30% in women was not statistically significant. Amel and al [<xref ref-type="bibr" rid="scirp.115245-ref8">8</xref>] reported that it is generally accepted that men and women have the same risk of being infected at any age confirming the results of our series. However, Houria and al reported that women are the most infected with Hp compared to men [<xref ref-type="bibr" rid="scirp.115245-ref9">9</xref>]. Also other studies found male predominance [<xref ref-type="bibr" rid="scirp.115245-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref13">13</xref>].</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of patients by gastric histological lesions associated with the presence of Hp</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >H. pylori Status</th><th align="center" valign="middle"  colspan="3"  >Total n = 510</th><th align="center" valign="middle"  colspan="2"  >Hp (+) n = 339</th><th align="center" valign="middle" >Hp (−) n = 171</th><th align="center" valign="middle"  colspan="2"  >p</th><th align="center" valign="middle" >OR (IC 95%)</th></tr></thead><tr><td align="center" valign="middle" >Malignant gastric tumor</td><td align="center" valign="middle"  colspan="3"  >51 (0.10%)</td><td align="center" valign="middle"  colspan="2"  >16 (31.37%)</td><td align="center" valign="middle" >35 (68.63%)</td><td align="center" valign="middle"  colspan="2"  >0.001</td><td align="center" valign="middle" >0.19 (0.1 - 0.35)</td></tr><tr><td align="center" valign="middle" >Chronic gastritis</td><td align="center" valign="middle"  colspan="3"  >413 (80.98%)</td><td align="center" valign="middle"  colspan="2"  >334 (80.87%)</td><td align="center" valign="middle" >79 (19.13%)</td><td align="center" valign="middle"  colspan="2"  >0.001</td><td align="center" valign="middle" >77.79 (30 - 187)</td></tr><tr><td align="center" valign="middle" >Active gastritis</td><td align="center" valign="middle"  colspan="3"  >363 (71.17%)</td><td align="center" valign="middle"  colspan="2"  >333 (91.74%)</td><td align="center" valign="middle" >30 (8.26%)</td><td align="center" valign="middle"  colspan="2"  >0.001</td><td align="center" valign="middle" >260 (106 - 640)</td></tr><tr><td align="center" valign="middle" >Reactive gastritis</td><td align="center" valign="middle"  colspan="3"  >66 (12.94%)</td><td align="center" valign="middle"  colspan="2"  >3 (4.55%)</td><td align="center" valign="middle" >63 (95.45%)</td><td align="center" valign="middle"  colspan="2"  >0.001</td><td align="center" valign="middle" >0.01 (0.005 - 0.05)</td></tr><tr><td align="center" valign="middle" >Mucosal atrophy</td><td align="center" valign="middle"  colspan="3"  >64 (12.54%)</td><td align="center" valign="middle"  colspan="2"  >45 (70.31%)</td><td align="center" valign="middle" >19 (29.69%)</td><td align="center" valign="middle"  colspan="2"  >0.46</td><td align="center" valign="middle" >1.24 (0.69 - 2.17)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Intestinal metaplasia</td><td align="center" valign="middle" >48 (9.41%)</td><td align="center" valign="middle"  colspan="2"  >32 (66.67%)</td><td align="center" valign="middle"  colspan="3"  >16 (33.33%)</td><td align="center" valign="middle" >0.97</td><td align="center" valign="middle" >1.01 (0.53 - 1.89)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>OR: odds ratio; CI: 95% confidence interval.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Association of gastric precancerous lesions and chronic gastritis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Stomach histology</th><th align="center" valign="middle" >Chronic gastritis (+) n = 413</th><th align="center" valign="middle" >Chronic gastritis (−) n = 97</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >OR (CI 95%)</th></tr></thead><tr><td align="center" valign="middle" >Mucosal atrophy</td><td align="center" valign="middle" >61 (95.31%)</td><td align="center" valign="middle" >3 (4.69%)</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >3.83 (1.66 - 17.69)</td></tr><tr><td align="center" valign="middle" >Intestinal metaplasia</td><td align="center" valign="middle" >45 (93.75%)</td><td align="center" valign="middle" >3 (6.25%)</td><td align="center" valign="middle" >0.01</td><td align="center" valign="middle" >1.01 (1.16 - 12.60)</td></tr></tbody></table></table-wrap><p>OR: odds ratio; IC: Confidence interval 95%.</p><p>Regarding age, our results are similar to a study conducted in C&#244;te d’Ivoire, where no significant differences in age were reported [<xref ref-type="bibr" rid="scirp.115245-ref14">14</xref>]. He argues that in Africa, every adult, regardless of socio-economic status, had a childhood in an environment conducive to contamination [<xref ref-type="bibr" rid="scirp.115245-ref9">9</xref>].</p><p>Some studies confirm the association between Hp and urban poverty related to hygiene conditions [<xref ref-type="bibr" rid="scirp.115245-ref15">15</xref>]. In our study, place of residence and occupation did not significantly influence the presence of Hp. Our results correspond to the work of Andoulo et al. [<xref ref-type="bibr" rid="scirp.115245-ref16">16</xref>].</p><p>Epigastralgia accounted for about two-thirds of the indications of positive Hp patients. However, there is no link between this indication and the presence of Hp in our study (p = 0.35). A significant difference was observed only for weight loss between positive and negative Hp patients (p = 0.03). This difference could be explained by stenosis syndrome, which is usually responsible for weight loss in gastric tumors. The link between gastric adenocarcinoma and Hp is well established according to the literature [<xref ref-type="bibr" rid="scirp.115245-ref17">17</xref>].</p><p>Although the prevalence of Hp in gastric ulcers is high (68.87%). There is no significant link in our study between gastric ulcer and Hp. The link between duodenal ulcers and Hp is well established according to the literature [<xref ref-type="bibr" rid="scirp.115245-ref18">18</xref>]. However, it should be noted that our study was retrospective. Patients taking proton pump inhibitors or antibiotics may have false-negative histological results for Hp. Which could probably explain our results.</p><p>Hp infection is the most important risk factor for chronic gastritis, gastric atrophy and intestinal metaplasia and is considered the precursor to gastric cancer [<xref ref-type="bibr" rid="scirp.115245-ref19">19</xref>]. In our work, chronic gastritis and active gastritis were significantly higher in Hp (+) patients and were a risk factor with an OR of 77.79 and 260 respectively in accordance with the literature data [<xref ref-type="bibr" rid="scirp.115245-ref12">12</xref>]. The frequencies of atrophic gastritis and intestinal metaplasia are low in our study. The studies carried out in sub-Saharan Africa also noted a low frequency of intestinal metaplasia of less than 20%. However, they showed a higher frequency of gastric atrophy of up to 75% [<xref ref-type="bibr" rid="scirp.115245-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref7">7</xref>]. In his review of the literature, Archampong noted that precancerous lesions (gastric atrophy and intestinal metaplasia) are not uncommon in symptomatic patients undergoing endoscopy in tertiary health facilities in Africa. Most hospital-based endoscopic studies showed prevalence rates of gastric atrophy of 5% - 38% and for intestinal metaplasia of 4% - 32% among populations in sub-Saharan Africa [<xref ref-type="bibr" rid="scirp.115245-ref20">20</xref>]. The presence of Hp was not significantly associated with gastric atrophy and intestinal metaplasia in our study. These gastric histological lesions are considered by several authors to be significantly related to the presence of Hp [<xref ref-type="bibr" rid="scirp.115245-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref22">22</xref>]. Inflammation and atrophy of the gastric mucosa are known to be factors that are not conducive to the development of Hp [<xref ref-type="bibr" rid="scirp.115245-ref20">20</xref>]. In addition, the lack of information in our study on the use of pump inhibitors or antibiotics could influence the search for hp during pathological examination [<xref ref-type="bibr" rid="scirp.115245-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.115245-ref20">20</xref>]. The absence of link between these gastric precancerous lesions and the presence of Hp in our study could therefore be explained by these two conditions. For tumours, Hp was shown to be a determining factor in the etiology of gastric cancers [<xref ref-type="bibr" rid="scirp.115245-ref17">17</xref>]. In our work, tumour lesions are significantly associated with Hp with a predominance of tumour lesions in case of Hp negative. Some authors would explain this result by “the African sub-Saharan enigma”, because of an ancient early childhood infection in sub-Saharan Africans, the human and host response to Hp could be protective against a virulent organism and that, in most people, Hp would not cause more serious sequelae. This would suggest that there may be host-protective/inhibiting factors that would prevent the progression of Hp-induced active gastritis to cancer [<xref ref-type="bibr" rid="scirp.115245-ref23">23</xref>]. This theory is nevertheless challenged by other authors such as Agha and Graham through a multicentre study [<xref ref-type="bibr" rid="scirp.115245-ref24">24</xref>].</p><p>The retrospective nature of our study could underestimate the prevalence of Hp through selection bias. It is not known whether the patients were on antibiotic therapy and or under a proton pump inhibitor when the gastric biopsy was performed. Despite this limitation, our study gives interesting results.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The prevalence of Helicobacter pylori is high in Bouak&#233;, like are other cities in developing countries. This study confirmed the involvement of Hp in chronic and active gastritis. Performing gastric biopsies in search of Hp during upper digestive endoscopies should be systematic. It would also be interesting to carry out a prospective multicentre study to clarify the links between Hp and precancerous and cancerous gastric lesions.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Our thanks to Prof. N’dah Kouam&#233; Justin and Dr. Aman N’guiessan Alphonse from the Pathological Anatomy Department of Bouak&#233;’s Teaching Hospital.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Diakit&#233;, M., Kon&#233;, A., Ak&#233;, A.F., Koffi, K.O.C., Okon, A.J.B. and Diallo, K. (2022) Helicobacter pylori Infection and Gastroduodenal Lesions: Prevalence and Associated Factors in Cote D’Ivoire. Open Journal of Gastroenterology, 12, 27-35. https://doi.org/10.4236/ojgas.2022.122003</p></sec></body><back><ref-list><title>References</title><ref id="scirp.115245-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Hunt, R.H., Xiao, S.D., Megraud, F., Leon-Barua, R., Bazzoli, F., van der Merwe, S., et al. (2011) Helicobacter pylori in Developing Countries. World Gastroenterology Organisation Global Guideline. Journal of Gastrointestinal and Liver Diseases, 20, 299-304.</mixed-citation></ref><ref id="scirp.115245-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Maury, F., Lozniewski, A., Floquet, J. and Plénat F. (1998) De la gastrite chronique au cancer gastrique: Roles de Helicobacter pylori et aspects anatomopathologiques. La Lettre de L’Hépato-Gastroentérologue, No. 1, 13-17.</mixed-citation></ref><ref id="scirp.115245-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Brown, L.M. (2000) Helicobacter pylori: Epidemiology and Routes of Transmission. Epidemiologic Reviews, 22, 283-297. https://doi.org/10.1093/oxfordjournals.epirev.a018040</mixed-citation></ref><ref id="scirp.115245-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Lamarque, D., Burucoa, C., Courillon-Mallet, A., de Korwin, J.D., et al. (2012) Révision des recommandations francaises sur la prise en charge de l’infection par Helicobacter pylori. Hépato Gastro et Oncologie digestive, 19, 475-502.</mixed-citation></ref><ref id="scirp.115245-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ankouane, F., Noah, D.N., Enyime, F.N., Ndjollé, C.M., Djapa, R.N., Nonga, B.N., et al. (2015) Helicobacter pylori and Precancerous Conditions of the Stomach: The Frequency of Infection in a Cross-Sectional Study of 79 Consecutive Patients with Chronic Antral Gastritis in Yaoundé, Cameroon. Pan African Medical Journal, 20, Article No. 52. https://doi.org/10.11604/pamj.2015.20.52.5887</mixed-citation></ref><ref id="scirp.115245-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Cosar, A.M. (2018) Effect of Cumulative Time of Helicobacter pylori Infection on Gastric Precancerous Lesions? Turkish Journal of Gastroenterology, 29, 524-525. https://doi.org/10.5152/tjg.2018.270618</mixed-citation></ref><ref id="scirp.115245-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Attia, K.A., N’dri Yoman, T., Diomandé, M.I., Mahassadi, A., et al. (2001) Aspects cliniques, endoscopiques et histologiques des gastrites chroniques à Helicobacter pylori en Cote d’Ivoire: étude de 102 patients. Bulletin de la Société de pathologie exotique, 94, 5-7.</mixed-citation></ref><ref id="scirp.115245-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Essadik, A., Benomar, H., Rafik, I., Hamza, M., Guemouri, L., Kettani, A., et al. (2013) Aspects épidémiologiques et cliniques de l’infection à Helicobacter pylori à travers une étude marocaine. Hegel, No. 3, 163-169. https://doi.org/10.4267/2042/51450</mixed-citation></ref><ref id="scirp.115245-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Kasmi, H., Doukani, K., Ali, A., Tabak, S., et al. (2020) Epidemiological Profile of Helicobacter pylori Infection in Patients with Digestive Symptoms in Algeria. Journal of Epidemiology and Global Health, 10, 293-297. https://doi.org/10.2991/jegh.k.200527.001</mixed-citation></ref><ref id="scirp.115245-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ramanampamonjy, R.M., Randria, M.J.D., Razafimahefa, S.H., Ratsimandisa, R., et al. (2007) Séroprévalence de l’infection due à Helicobacter pylori dans un échantillon de population malgache. Bulletin de la Société de Pathologie Exotique, 100, 57-60.</mixed-citation></ref><ref id="scirp.115245-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bagny, A., Darre, T., Bouglouga, O., Lawson-Ananissoh, L.M., et al. (2014) Gastrite chronique à Helicobacter pylori au CHU campus de Lomé. Journal de la Recherche Scientifique de l’Université de Lomé, 16, 495-502.</mixed-citation></ref><ref id="scirp.115245-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Dia, D., Seck, A., Mbengue, M., Bassène, M.L., Breurec, S., Fall, B., et al. (2010) Helicobacter pylori et pathologie gastroduodenale à Dakar (Sénégal). Tropical Medicine, 70, 367-370.</mixed-citation></ref><ref id="scirp.115245-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Khalife, H., Khalife, H., Haidar Hassan, K., Ghssein, G., El Rashed, Z. and Abdel-Sater, F. (2017) Epidemiology of Helicobacter pylori Infection among the Healthy Population in Lebanon. World Journal of Pharmaceutical Sciences, 6, 363-372. https://doi.org/10.20959/wjpps20176-9298</mixed-citation></ref><ref id="scirp.115245-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Vilaichone, R., Mahachai, V., Shiota, S., Uchida, T., Ratanachu-ek, T., Tshering, L., et al. (2013) Extremely High Prevalence of Helicobacter pylori Infection in Bhutan. World Journal of Gastroenterology, 19, 2806-2810. https://doi.org/10.3748/wjg.v19.i18.2806</mixed-citation></ref><ref id="scirp.115245-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Epplein, M., Signorello, L.B., Zheng, W., Peek, R.M., Michel, A., Williams, S.M., et al. (2011) Race, African Ancestry, and Helicobacter pylori Infection in a Low-Income United States Population. Cancer Epidemiology, Biomarkers &amp; Prevention, 20, 826-834. https://doi.org/10.1158/1055-9965.EPI-10-1258</mixed-citation></ref><ref id="scirp.115245-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Andoulo, F.A., Noah, D.N., Tagni-Sartre, M., Ndam, E.C.N., et al. (2013) Epidémiologie de l’infection à Helicobacter pylori à Yaoundé: De la particularité à l’énigme Africaine. Pan African Medical Journal, 16, Article No. 115. https://doi.org/10.11604/pamj.2013.16.115.3007</mixed-citation></ref><ref id="scirp.115245-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Trindade, L.M.D.F., de Oliveira Menezes, L.B., de Souza Neta, A.M., Rolemberg, P.C.L., et al. (2017) Prevalence of Helicobacter pylori Infection in Samples of Gastric Biopsies. Gastroenterology Research, 10, 33-41. https://doi.org/10.14740/gr785w</mixed-citation></ref><ref id="scirp.115245-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Bommelaer, G. and Stef, A. (2009) Ulcère gastroduodénal: Avant et après Helicobacter pylori. Gastroentérologie Clinique et Biologique, 33, 626-634. https://doi.org/10.1016/j.gcb.2009.07.004</mixed-citation></ref><ref id="scirp.115245-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Park, Y.H. and Kim, N. (2015) Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer. Journal of Cancer Prevention, 20, 25-40. https://doi.org/10.15430/JCP.2015.20.1.25</mixed-citation></ref><ref id="scirp.115245-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Archampong, T.N., Asmah, R.H., Richards, C.J., Martin, V.J., et al. (2019) Gastro-Duodenal Disease in Africa: Literature Review and Clinical Data from Accra, Ghana. World Journal of Gastroenterology, 25, 3344-3358. https://doi.org/10.3748/wjg.v25.i26.3344</mixed-citation></ref><ref id="scirp.115245-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Rodrigues, M.F., Guerra, M.R., de Alvarenga, A.V.R., Souza, D.Z., et al. (2019) Helicobacter pylori Infection and Gastric Cancer Precursor Lesions: Prevalence and Associated Factors in a Reference Laboratory in Southeastern Brazil. Arquivos de Gastroenterologia, 56, 419-424. https://doi.org/10.1590/s0004-2803.201900000-84</mixed-citation></ref><ref id="scirp.115245-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Olmez, S., Aslan, M., Erten, R., Sayar, S., et al. (2015) The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes. Gastroenterology Research and Practice, 2015, Article ID: 434039. https://doi.org/10.1155/2015/434039</mixed-citation></ref><ref id="scirp.115245-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Segal, I., Ally, R. and Mitchell, H. (2001) Gastric Cancer in Sub-Saharan Africa. European Journal of Cancer Prevention, 10, 479-482. https://doi.org/10.1097/00008469-200112000-00001</mixed-citation></ref><ref id="scirp.115245-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Agha, A. and Graham, D.Y. (2005) Evidence-Based Examination of the African Enigma in Relation to Helicobacter pylori Infection. Scandinavian Journal of Gastroenterology, 40, 523-529. https://doi.org/10.1080/00365520510012280</mixed-citation></ref></ref-list></back></article>